相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutant LRRK2 Elicits Calcium Imbalance and Depletion of Dendritic Mitochondria in Neurons
Salvatore J. Cherra et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway
Jose M. Bravo-San Pedro et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Autophagy and microtubules - new story, old players
Rafah Mackeh et al.
JOURNAL OF CELL SCIENCE (2013)
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
Patricia Silva Guerreiro et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Interplay of LRRK2 with chaperone-mediated autophagy
Samantha J. Orenstein et al.
NATURE NEUROSCIENCE (2013)
Cerebrospinal fluid biomarkers in Parkinson disease
Lucilla Parnetti et al.
NATURE REVIEWS NEUROLOGY (2013)
Leucine-rich repeat kinase 2 functionally interacts with microtubules and kinase-dependently modulates cell migration
Mareike Caesar et al.
NEUROBIOLOGY OF DISEASE (2013)
Biomarkers in Parkinson's disease (recent update)
Sushil Sharma et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease
Maria Sierra et al.
NEUROLOGY (2013)
RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson's Disease Risk
David A. MacLeod et al.
NEURON (2013)
Leucine-Rich Repeat Kinase 2 (LRRK2)-Deficient Rats Exhibit Renal Tubule Injury and Perturbations in Metabolic and Immunological Homeostasis
Daniel Ness et al.
PLOS ONE (2013)
Pharmacological inhibition of LRRK2 cellular phosphorylation sites provides insight into LRRK2 biology
Jing Zhao et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
A link between LRRK2, autophagy and NAADP-mediated endolysosomal calcium signalling
Patricia Gomez-Suaga et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
Iakov N Rudenko et al.
BMC Medicine (2012)
Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism
Bart F. L. van Nuenen et al.
BRAIN (2012)
Transcriptional and Nontranscriptional Functions of E2F1 in Response to DNA Damage
Anup K. Biswas et al.
CANCER RESEARCH (2012)
Quantitative functions of Argonaute proteins in mammalian development
Dongmei Wang et al.
GENES & DEVELOPMENT (2012)
LRRK2 Parkinson disease mutations enhance its microtubule association
Lauren R. Kett et al.
HUMAN MOLECULAR GENETICS (2012)
Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning
Mark W. Dodson et al.
HUMAN MOLECULAR GENETICS (2012)
Phosphorylation of α-Synuclein Protein at Ser-129 Reduces Neuronal Dysfunction by Lowering Its Membrane Binding Property in Caenorhabditis elegans
Tomoki Kuwahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling
Huifen Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Disrupted Autophagy Leads to Dopaminergic Axon and Dendrite Degeneration and Promotes Presynaptic Accumulation of α-Synuclein and LRRK2 in the Brain
Lauren G. Friedman et al.
JOURNAL OF NEUROSCIENCE (2012)
The neuropathology of genetic Parkinson's disease
Markos Poulopoulos et al.
MOVEMENT DISORDERS (2012)
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2
Guang-Hui Liu et al.
NATURE (2012)
Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriers
J. O. Aasly et al.
NEUROLOGY (2012)
LRRK2 Controls an EndoA Phosphorylation Cycle in Synaptic Endocytosis
Samer Matta et al.
NEURON (2012)
LRRK2 I2020T mutation is associated with tau pathology
Sachiko Ujiie et al.
PARKINSONISM & RELATED DISORDERS (2012)
LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth
Fumitaka Kawakami et al.
PLOS ONE (2012)
Microtubule Destabilization Is Shared by Genetic and Idiopathic Parkinson's Disease Patient Fibroblasts
Daniele Cartelli et al.
PLOS ONE (2012)
α-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers
Ana Gorostidi et al.
PLOS ONE (2012)
Brain Penetrant LRRK2 Inhibitor
Hwan Geun Choi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson's Disease-Related Toxicity in Human Neurons
Nigel Ramsden et al.
ACS CHEMICAL BIOLOGY (2011)
Identification of chemicals to inhibit the kinase activity of leucine-rich repeat kinase 2 (LRRK2), a Parkinson's disease-associated protein
HyeJin Yun et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
Ha Nam Nguyen et al.
CELL STEM CELL (2011)
Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models
Zhaohui Liu et al.
HUMAN MOLECULAR GENETICS (2011)
Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death
Dario C. Angeles et al.
HUMAN MUTATION (2011)
Microtubule-associated Protein 1B (MAP1B) Is Required for Dendritic Spine Development and Synaptic Maturation
Elena Tortosa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
Veronique Daniels et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies
Michael A. Nalls et al.
LANCET (2011)
Distinct Autophagosomal-Lysosomal Fusion Mechanism Revealed by Thapsigargin-Induced Autophagy Arrest
Ian G. Ganley et al.
MOLECULAR CELL (2011)
Rare and common LRRK2 exonic variants in Parkinson's disease
Eng-King Tan
LANCET NEUROLOGY (2011)
Association of LRRK2 exonic variants and susceptibility to Parkinson's disease: a case-control study (vol 10, pg 898, 2011)
O. A. Ross et al.
LANCET NEUROLOGY (2011)
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Xianming Deng et al.
NATURE CHEMICAL BIOLOGY (2011)
Mouse models for LRRK2 Parkinson's disease
Qing Xu et al.
PARKINSONISM & RELATED DISORDERS (2011)
Genetic variants in Sporadic Parkinson's Disease: East vs West
Tasneem Peeraully et al.
PARKINSONISM & RELATED DISORDERS (2011)
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study
Owen A. Ross et al.
LANCET NEUROLOGY (2011)
alpha-Synuclein: Membrane Interactions and Toxicity in Parkinson's Disease
Pavan K. Auluck et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 26 (2010)
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
Nicolas Dzamko et al.
BIOCHEMICAL JOURNAL (2010)
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
R. Jeremy Nichols et al.
BIOCHEMICAL JOURNAL (2010)
LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity
Hye Young Heo et al.
EXPERIMENTAL CELL RESEARCH (2010)
Development of Parkinson's disease biomarkers
Kumar M. Prakash et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in Drosophila
Tomoko Kanao et al.
HUMAN MOLECULAR GENETICS (2010)
LRRK2 Kinase Regulates Synaptic Morphology through Distinct Substrates at the Presynaptic and Postsynaptic Compartments of the Drosophila Neuromuscular Junction
Seongsoo Lee et al.
JOURNAL OF NEUROSCIENCE (2010)
Novel Pathogenic LRRK2 p.Asn1437His Substitution in Familial Parkinson's Disease
Jan O. Aasly et al.
MOVEMENT DISORDERS (2010)
Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression
Stephan Gehrke et al.
NATURE (2010)
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Byoung Dae Lee et al.
NATURE MEDICINE (2010)
Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
Christian Wider et al.
NEURODEGENERATIVE DISEASES (2010)
The Parkinson's Disease Associated LRRK2 Exhibits Weaker In Vitro Phosphorylation of 4E-BP Compared to Autophosphorylation
Azad Kumar et al.
PLOS ONE (2010)
Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice
Youren Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
LRRK2 in Parkinson's disease: genetic and clinical studies from patients
Udhaya Kumari et al.
FEBS JOURNAL (2009)
Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - a point of convergence in Parkinsonian neurodegeneration?
Frank Gillardon
JOURNAL OF NEUROCHEMISTRY (2009)
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake et al.
NATURE GENETICS (2009)
INTERACTION OF ELONGATION FACTOR 1-ALPHA WITH LEUCINE-RICH REPEAT KINASE 2 IMPAIRS KINASE ACTIVITY AND MICROTUBULE BUNDLING IN VITRO
F. Gillardon
NEUROSCIENCE (2009)
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
Yuzuru Imai et al.
EMBO JOURNAL (2008)
LRRK2 regulates synaptic vesicle endocytosis
Narae Shin et al.
EXPERIMENTAL CELL RESEARCH (2008)
Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease
Brinda Ravikumar et al.
JOURNAL OF CELL SCIENCE (2008)
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
Edward D. Plowey et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules
Payal N. Gandhi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Molecular biology changes associated with LRRK2 mutations in Parkinson's disease
Yi Wei Lu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Update on the functional biology of Lrrk2
Heather Melrose
FUTURE NEUROLOGY (2008)
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity
Mahaboobi Jaleel et al.
BIOCHEMICAL JOURNAL (2007)
Pathogenic mutations in Parkinson disease
Eng-King Tan et al.
HUMAN MUTATION (2007)
The R1441C mutation of LRRK2 disrupts GTP hydrolysis
Patrick A. Lewis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families
Etsuro Ohta et al.
NEUROSCIENCE LETTERS (2007)
Leucine-rich repeat kinase 2 associates with lipid rafts
Taku Hatano et al.
HUMAN MOLECULAR GENETICS (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain
Maria C. Gonzalez-Fernandez et al.
PARKINSONISM & RELATED DISORDERS (2007)
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease
L. N. Clark et al.
NEUROLOGY (2006)
LRRK2 protein is a component of Lewy bodies
Xiongwei Zhu et al.
ANNALS OF NEUROLOGY (2006)
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
Saskia Biskup et al.
ANNALS OF NEUROLOGY (2006)
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W. Smith et al.
NATURE NEUROSCIENCE (2006)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
Early-onset familial Parkinsonism due to POLG mutations
G Davidzon et al.
ANNALS OF NEUROLOGY (2006)
LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs
S Lesage et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
LJ Ozelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
CJ Gloeckner et al.
HUMAN MOLECULAR GENETICS (2006)
Vps9 domain-containing proteins: activators of Rab5 GTPases from yeast to neurons
DS Carney et al.
TRENDS IN CELL BIOLOGY (2006)
Lrrk2 pathogenic substitutions in Parkinson's disease
IF Mata et al.
NEUROGENETICS (2005)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations
CP Zabetian et al.
NEUROLOGY (2005)
Rab conversion as a mechanism of progression from early to late endosomes
J Rink et al.
CELL (2005)
Escaping Parkinson's disease:: A neurologically healthy octogenarian with the LRRK2 G2019S mutation
DM Kay et al.
MOVEMENT DISORDERS (2005)
Disruption of the MAP1B-related protein FUTSCH leads to changes in the neuronal cytoskeleton, axonal transport defects, and progressive neurodegeneration in Drosophila
AB da Cruz et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Parkinsonism, premature menopause, and mitochondrial DNA polymerase γ mutations:: clinical and molecular genetic study
P Luoma et al.
LANCET (2004)
The pathophysiology of mitochondrial cell death
DR Green et al.
SCIENCE (2004)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Roc, a Ras/GTPase domain in complex proteins
L Bosgraaf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2003)
Role of Drosophila Rab5 during endosomal trafficking at the synapse and evoked neurotransmitter release
T Wucherpfennig et al.
JOURNAL OF CELL BIOLOGY (2003)
Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds α-synuclein filaments
PH Jensen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
